CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 13  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.1107
LYS 10.0180
GLU 20.0211
LEU 30.0122
ARG 40.0155
CYS 50.0183
GLN 60.0208
CYS 70.0182
ILE 80.0242
LYS 90.0362
THR 100.0219
TYR 110.0201
SER 120.0241
LYS 130.0293
PRO 140.0263
PHE 150.0179
HIS 160.0067
PRO 170.0059
LYS 180.0089
PHE 190.0055
ILE 200.0063
LYS 210.0107
GLU 220.0126
LEU 230.0092
ARG 240.0133
VAL 250.0148
ILE 260.0167
GLU 270.0201
SER 280.0095
GLY 290.0180
PRO 300.0709
HIS 310.0221
CYS 320.0209
ALA 330.0319
ASN 340.0257
THR 350.0243
GLU 360.0197
ILE 370.0114
ILE 380.0093
VAL 390.0070
LYS 400.0109
LEU 410.0115
SER 420.0141
ASP 430.0231
GLY 440.0201
ARG 450.0147
GLU 460.0062
LEU 470.0051
CYS 480.0064
LEU 490.0062
ASP 500.0171
PRO 510.0230
LYS 520.0291
GLU 530.0081
ASN 540.0283
TRP 550.0224
VAL 560.0133
GLN 570.0240
ARG 580.0266
VAL 590.0153
VAL 600.0118
GLU 610.0168
LYS 620.0017
PHE 630.0054
LEU 640.0255
LYS 650.0360
ARG 660.0353
ALA 670.0426
GLU 680.0821
ASN 690.1107

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.